BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24423362)

  • 1. The impact of glucocorticoid replacement on bone mineral density in patients with hypopituitarism before and after 2 years of growth hormone replacement therapy.
    Ragnar Agnarsson H; Johannsson G; Ragnarsson O
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1479-85. PubMed ID: 24423362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study.
    Appelman-Dijkstra NM; Claessen KM; Hamdy NA; Pereira AM; Biermasz NR
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):727-35. PubMed ID: 24816144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
    Götherström G; Bengtsson BA; Bosaeus I; Johannsson G; Svensson J
    Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients.
    Ragnarsson O; Mattsson AF; Monson JP; Filipsson Nyström H; Åkerblad AC; Kołtowska-Häggström M; Johannsson G
    Eur J Endocrinol; 2014 Nov; 171(5):571-9. PubMed ID: 25127712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
    Johannsson G; Sunnerhagen KS; Svensson J
    Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism.
    Ragnarsson O; Nyström HF; Johannsson G
    Clin Endocrinol (Oxf); 2012 Feb; 76(2):246-52. PubMed ID: 21767286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.
    Drake WM; Rodríguez-Arnao J; Weaver JU; James IT; Coyte D; Spector TD; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):525-32. PubMed ID: 11318789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency.
    Elbornsson M; Götherström G; Bosæus I; Bengtsson BÅ; Johannsson G; Svensson J
    Eur J Endocrinol; 2012 May; 166(5):787-95. PubMed ID: 22318746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of raloxifene and estrogen on body composition in growth hormone-replaced hypopituitary women.
    Birzniece V; Meinhardt UJ; Gibney J; Johannsson G; Armstrong N; Baxter RC; Ho KK
    J Clin Endocrinol Metab; 2012 Mar; 97(3):1005-12. PubMed ID: 22170716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender.
    Rota F; Savanelli MC; Tauchmanova L; Savastano S; Lombardi G; Colao A; Di Somma C
    J Endocrinol Invest; 2008 Feb; 31(2):94-102. PubMed ID: 18362499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B; Kann PH
    Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement.
    Gómez JM; Gómez N; Fiter J; Soler J
    Horm Metab Res; 2000 Feb; 32(2):66-70. PubMed ID: 10741688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism.
    Kosowicz J; El Ali Z; Ziemnicka K; Sowinski J
    J Clin Densitom; 2007; 10(3):332-9. PubMed ID: 17470407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.
    Filipsson H; Monson JP; Koltowska-Häggström M; Mattsson A; Johannsson G
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3954-61. PubMed ID: 16895963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRABECULAR BONE SCORE CHANGE DIFFERS WITH REGARD TO 25(OH)D LEVELS IN PATIENTS TREATED FOR ADULT-ONSET GROWTH HORMONE DEFICIENCY.
    Kužma M; Binkley N; Bednárová A; Killinger Z; Vaňuga P; Payer J
    Endocr Pract; 2016 Aug; 22(8):951-8. PubMed ID: 27042750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency.
    Snyder PJ; Biller BM; Zagar A; Jackson I; Arafah BM; Nippoldt TB; Cook DM; Mooradian AD; Kwan A; Scism-Bacon J; Chipman JJ; Hartman ML
    J Bone Miner Res; 2007 May; 22(5):762-70. PubMed ID: 17280527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.